{"id":15764,"date":"2025-02-18T17:03:01","date_gmt":"2025-02-18T15:03:01","guid":{"rendered":"https:\/\/adragos-pharma.com\/?p=15764"},"modified":"2025-05-09T09:28:20","modified_gmt":"2025-05-09T07:28:20","slug":"understanding-the-differences-large-molecules-vs-small-molecules","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/understanding-the-differences-large-molecules-vs-small-molecules\/","title":{"rendered":"Understanding the Differences: Large Molecules vs. Small Molecules"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The pharmaceutical industry relies on two primary types of drugs: <a rel=\"noopener noreferrer\" href=\"https:\/\/adragos-pharma.com\/small-molecule-drugs-explained\/\"><strong>small molecules<\/strong><\/a> and <strong>large molecules<\/strong>. Both play essential roles in modern medicine, yet they differ significantly in structure, function, and production methods. Understanding these differences between small and large molecules is crucial for professionals involved in <strong>drug development<\/strong> and <strong>manufacturing processes<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This article explores the characteristics of <strong>large molecules<\/strong>, how they compare to <strong>small molecules<\/strong>, and their impact on <strong>pharmaceutical drug development<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Defining Large Molecules: Characteristics and Importance<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What Are Large Molecules?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Large molecules<\/strong>, or <strong>biologics<\/strong>, have a <strong>large molecular weight<\/strong> and are manufactured or extracted <strong>from living organisms<\/strong>. They are made of proteins that are complex in structure and much less stable compared to small molecule drugs. Unlike <strong>small molecule drugs<\/strong>, which mostly are chemically synthesized, <strong>large molecules<\/strong> are derived from <strong>living cells<\/strong>. Their complexity enables them to target specific biological processes with high precision, making them highly effective in treating various diseases, including cancer and autoimmune disorders. Effective biologics characterization relies heavily on robust process development to ensure successful outcomes in a phase-appropriate manner.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Key Characteristics of Large Molecules<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>High molecular weight:<\/strong> Typically larger than <strong>small molecule drugs<\/strong>, requiring specialized analytical techniques such as <strong>mass spectrometry (LC-MS)<\/strong> and <strong>size exclusion chromatography<\/strong>.<\/li>\n\n\n\n<li><strong>Biological origin:<\/strong> Produced using <strong>living organisms<\/strong>, often requiring <strong>cell line development<\/strong> and <strong>upstream\/downstream processing<\/strong>.<\/li>\n\n\n\n<li><strong>Complex structures:<\/strong> Involves intricate <strong>chemical bonds<\/strong> and <strong>post-translational modifications<\/strong> that affect function and stability.<\/li>\n\n\n\n<li><strong>Specific mode of action:<\/strong> Often designed to interact with particular cellular targets, such as <strong>monoclonal antibodies<\/strong> that bind to antigens.<\/li>\n\n\n\n<li><strong>Limited oral bioavailability:<\/strong> Due to their size and instability in the digestive system, most <strong>large molecule drugs<\/strong> are administered via <strong>injection or intravenous infusion<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Small Molecules: A Comparison<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What Are Small Molecules?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Small molecules<\/strong> are low <strong>molecular weight<\/strong> compounds that can be synthesized through <strong>organic chemistry<\/strong>. They form the foundation of many traditional <strong>pharmaceutical drugs<\/strong>, including antibiotics, pain relievers, and cardiovascular medications.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>How Do Small Molecules Differ from Large Molecules?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Size and molecular weight:<\/strong> <strong>Small molecules<\/strong> typically have a <strong>low molecular weight<\/strong>, allowing them to diffuse easily across cell membranes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Chemical synthesis:<\/strong> Unlike <strong>large molecules<\/strong>, which require <strong>living cells<\/strong> for production, <strong>small molecules<\/strong> are usually created through well-established <strong>synthetic drug<\/strong> processes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Drug administration:<\/strong> Many <strong>small molecule drugs<\/strong> can be taken orally, whereas <strong>large molecules<\/strong> require specialized <strong>drug delivery<\/strong> systems.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Regulatory considerations:<\/strong> <strong>Small molecules<\/strong> generally have simpler <strong>FDA approval<\/strong> pathways compared to <strong>large molecules<\/strong>, which undergo extensive testing for <strong>immunogenicity, binding assays<\/strong>, and <strong>clinical trial<\/strong> phases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">While <strong>small molecule drugs<\/strong> remain widely used, <strong>large molecules<\/strong> have become increasingly important due to their ability to address diseases that previously had limited treatment options. Maintaining the integrity of large molecules during the entire analytical process is crucial to ensure accurate and reliable results.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The Manufacturing Process for Large Molecules<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Production Through Living Cells<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Developing <strong>large molecule drugs<\/strong> is significantly more complex than producing <strong>small molecule drugs<\/strong>. Since <strong>large molecules<\/strong> are typically derived from <strong>living cells<\/strong>, the <strong>manufacturing process<\/strong> involves multiple critical steps, including:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cell line development:<\/strong> Selecting and optimizing <strong>cell lines<\/strong> capable of producing the required protein or <strong>monoclonal antibody<\/strong>.<\/li>\n\n\n\n<li><strong>Upstream processing:<\/strong> Cultivating the cells in bioreactors under controlled conditions to maximize protein production.<\/li>\n\n\n\n<li><strong>Downstream processing:<\/strong> Using techniques such as <strong>ion exchange chromatography<\/strong> and <strong>reversed-phase chromatography<\/strong> to purify the <strong>large molecule drug<\/strong>.<\/li>\n\n\n\n<li><strong>Quality control:<\/strong> Ensuring <strong>data integrity<\/strong> and consistency in <strong>molecular weight, chemical structure<\/strong>, and biological activity.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The <strong>pharmaceutical drug development<\/strong> of <strong>large molecules<\/strong> requires sophisticated <strong>method development<\/strong> to maintain stability and efficacy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The Role of Large Molecules in Drug Development<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Monoclonal Antibodies and Therapeutic Proteins<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">One of the most significant advancements in <strong>large molecule therapeutics<\/strong> has been the development of <strong>monoclonal antibodies<\/strong>. These laboratory-engineered proteins are designed to recognize and bind to specific antigens, making them highly effective for targeted therapies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Examples include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Herceptin (trastuzumab):<\/strong> Used for breast cancer treatment.<\/li>\n\n\n\n<li><strong>Humira (adalimumab):<\/strong> A <strong>monoclonal antibody<\/strong> that blocks inflammation in autoimmune diseases.<\/li>\n\n\n\n<li><p><strong>Bevacizumab:<\/strong> Used in cancer therapy to inhibit blood vessel growth in tumors.<\/p><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Additionally, <strong>therapeutic proteins<\/strong> such as <strong>insulin<\/strong> and <strong>growth factors<\/strong> have transformed the treatment of metabolic and genetic disorders.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/02\/comparisons-molecules-1024x576.jpg\" alt=\"small molecules vs large molecules\" class=\"wp-image-15769\" srcset=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/02\/comparisons-molecules-1024x576.jpg 1024w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/02\/comparisons-molecules-300x169.jpg 300w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/02\/comparisons-molecules-768x432.jpg 768w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/02\/comparisons-molecules-1536x864.jpg 1536w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/02\/comparisons-molecules.jpg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<h3 class=\"wp-block-heading\"><strong>Gene Therapy and Nucleic Acids<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Recent advancements in <strong>genetic information<\/strong> have led to the development of <strong>nucleic acid-based<\/strong> therapies. These <strong>large molecules<\/strong>, including <strong>DNA and RNA<\/strong>, play a crucial role in <strong>exon skipping<\/strong> strategies for genetic diseases and <strong>cell-mediated<\/strong> therapies.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Benefits and Limitations of Small and Large Molecule Drugs<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Efficacy and Safety Considerations<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Both <strong>small<\/strong> and <strong>large molecule drugs<\/strong> have unique benefits and limitations that must be carefully considered during the <strong><a href=\"https:\/\/adragos-pharma.com\/the-drug-development-process-a-closer-look-at-its-meaning-and-its-phases\/\">drug development process<\/a>.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Small molecule drugs<\/strong> are often favored for their <strong>ease of synthesis, optimization, and administration<\/strong>. Their <strong>low molecular weight<\/strong> allows them to <strong>diffuse easily across cell membranes<\/strong>, making them effective for treating a <strong>wide range<\/strong> of diseases. Additionally, many <strong>small molecule drugs<\/strong> can be taken <strong>orally<\/strong>, which is convenient for patients. However, <strong>small molecules<\/strong> can also have limitations, such as <strong>off-target effects, toxicity, and limited bioavailability<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Large molecule drugs<\/strong>, on the other hand, are known for their ability to <strong>target complex biological pathways<\/strong> and <strong>modulate immune responses<\/strong>. These drugs, often derived from <strong>living cells<\/strong>, can be designed to interact with specific <strong>cell surface receptors<\/strong>, making them highly effective for treating diseases such as <strong>cancer and autoimmune disorders<\/strong>. However, <strong>large molecules<\/strong> also present challenges, including <strong>difficulty in synthesis and optimization, limited bioavailability, and potential immunogenicity<\/strong>. Due to their <strong>size and complexity<\/strong>, <strong>large molecule drugs<\/strong> are typically administered via <strong>injection or intravenous infusion<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Efficacy<\/strong> and <strong>safety considerations<\/strong> are critical when developing both <strong>small<\/strong> and <strong>large molecule drugs<\/strong>. This involves carefully evaluating the <strong>potential benefits and risks<\/strong> of each drug, as well as their <strong>interactions with other medications and biological systems<\/strong>. By understanding these factors, researchers and clinicians can develop <strong>effective and safe treatments<\/strong> for a <strong>wide range<\/strong> of diseases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In conclusion, the development of <strong>small<\/strong> and <strong>large molecule drugs<\/strong> requires a deep understanding of their <strong>benefits and limitations<\/strong>, as well as their <strong>potential interactions with biological systems<\/strong>. By carefully considering these factors, researchers and clinicians can develop <strong>effective and safe treatments<\/strong> for a <strong>wide range<\/strong> of diseases.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Regulatory Challenges and FDA Approval<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Complexity of Large Molecule Approval<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Because <strong>large molecules<\/strong> are derived from <strong>living organisms<\/strong>, their <strong>FDA approval<\/strong> process is more rigorous than that of <strong>small molecules<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Regulatory agencies require extensive data on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Binding assays and ligand binding assays<\/strong> to confirm specificity.<\/li>\n\n\n\n<li><strong>Post-translational modifications<\/strong> that could affect efficacy.<\/li>\n\n\n\n<li><strong>Clinical trials<\/strong> to assess <strong>drug administration, immunogenicity testing, and controlled release<\/strong> mechanisms.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Companies must also ensure consistency in <a rel=\"noopener noreferrer\" href=\"https:\/\/adragos-pharma.com\/drug-product-vs-drug-substance-key-differences-you-should-know\/\"><strong>drug substance<\/strong><\/a> production, as slight variations in the <strong>manufacturing process<\/strong> can impact safety and effectiveness.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The Future of Large Molecule Drugs<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Innovations in Drug Delivery<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">One of the biggest challenges in <strong>large molecule drug<\/strong> development is improving <strong>drug delivery<\/strong>. Researchers are exploring new approaches, such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Nanoparticles and fusion proteins<\/strong> for targeted delivery.<\/li>\n\n\n\n<li><strong>Continuous manufacturing<\/strong> to improve efficiency and scalability.<\/li>\n\n\n\n<li><strong>Alternative administration routes<\/strong> to move beyond injections and infusions.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Expanding Treatment Possibilities<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The continued research in <strong>large molecule therapeutics<\/strong> is expected to lead to groundbreaking treatments for rare diseases, cancer, and neurological conditions. The rise of <a rel=\"noopener noreferrer\" href=\"https:\/\/adragos-pharma.com\/the-impact-of-biosimilars-transforming-healthcare-and-patient-outcomes\/\"><strong>biosimilars<\/strong><\/a>\u2014highly similar versions of existing <strong>large molecule drugs<\/strong>\u2014also presents opportunities for making these therapies more affordable and accessible.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The distinction between <strong>small molecules<\/strong> and <strong>large molecules<\/strong> is fundamental to modern <strong>pharmaceutical drug development<\/strong>. While <strong>small molecule drugs<\/strong> continue to be essential for many conditions, <strong>large molecules<\/strong> have introduced new possibilities in <strong>biologics<\/strong>, <strong>monoclonal antibodies<\/strong>, and <strong>genetic medicine<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Despite the challenges in <strong>manufacturing, regulatory considerations, and drug delivery<\/strong>, <strong>large molecules<\/strong> remain a driving force in the future of medicine. As research advances, these drugs will continue to shape the industry, providing innovative solutions for some of the most challenging diseases.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-fe48e5de wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-secondary-background-color has-background wp-element-button\" href=\"https:\/\/adragos-pharma.com\/contact-us\/?utm_campaign=Banner_Blog_Articles&amp;utm_source=blog&amp;utm_medium=organic_search\">Do you want to know more about us?<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Frequently Asked Questions (FAQs)<\/strong> about Large Molecules<\/h2>\n\n\n\n<div class=\"wp-block-gutena-accordion gutena-accordion-block gutena-accordion-block-b4b3f7-f7 is-layout-flow wp-block-gutena-accordion-is-layout-flow\" data-single=\"true\">\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What are examples of large molecules?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">Examples include <strong>monoclonal antibodies, therapeutic proteins, nucleic acids (DNA, RNA), and enzymes<\/strong>. These drugs are widely used in treating cancer, autoimmune diseases, and genetic disorders.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What are very large molecules called?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">Extremely <strong>large molecules<\/strong> are often referred to as <strong>macromolecules<\/strong> or <strong>giant covalent structures<\/strong>, depending on their composition.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What are considered large molecules?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">A <strong>large molecule<\/strong> is any pharmaceutical compound with a high <strong>molecular weight<\/strong>, typically derived from <strong>living cells<\/strong>, and used in <strong>biologics<\/strong>. Examples include <strong>monoclonal antibodies, nucleic acids<\/strong>, and <strong>therapeutic proteins<\/strong>.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong><strong><strong>What is an example of a large molecule drug?<\/strong><\/strong><\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">Notable <strong>large molecule drugs<\/strong> include <strong>Humira (adalimumab)<\/strong> for autoimmune diseases, <strong>Herceptin (trastuzumab)<\/strong> for breast cancer, and <strong>insulin<\/strong> for diabetes.<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The pharmaceutical industry relies on two primary types of drugs: small molecules and large molecules. Both play essential roles in modern medicine, yet they differ significantly in structure, function, and production methods. Understanding these differences between small and large molecules [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":12264,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[13],"tags":[],"topics":[293,78],"locations":[23,274],"experts":[],"class_list":["post-15764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","topics-biologics","topics-cdmo","locations-athens","locations-jura"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/15764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/comments?post=15764"}],"version-history":[{"count":5,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/15764\/revisions"}],"predecessor-version":[{"id":15780,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/15764\/revisions\/15780"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media\/12264"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media?parent=15764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/categories?post=15764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/tags?post=15764"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/topics?post=15764"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/locations?post=15764"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/experts?post=15764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}